These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 15251321
21. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS. Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411 [Abstract] [Full Text] [Related]
27. Recurrence of IgA nephropathy after renal transplantation. van der Boog PJ, de Fijter JW, Bruijn JA, van Es LA. Ann Med Interne (Paris); 1999 Feb 27; 150(2):137-42. PubMed ID: 10392262 [Abstract] [Full Text] [Related]
28. IgA nephropathy in renal transplant recipients: is it a significant cause of allograft failure? Park SB, Joo I, Suk J, Cho WH, Park CH, Kim SP, Park KK, Kim HC. Transplant Proc; 1996 Jun 27; 28(3):1540-2. PubMed ID: 8658777 [No Abstract] [Full Text] [Related]
29. Recurrence of IgA nephropathy with crescents in kidney transplants. Mousson C, Charon-Barra C, Funes de la Vega M, Tanter Y, Justrabo E, Martin L, Rifle G. Transplant Proc; 2007 Oct 27; 39(8):2595-6. PubMed ID: 17954186 [Abstract] [Full Text] [Related]
30. The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy. Zaltzman JS, Nash M, Chiu R, Prasad R. Nephrol Dial Transplant; 2004 Apr 27; 19(4):940-4. PubMed ID: 15031353 [Abstract] [Full Text] [Related]
33. Glomerular pathology of allograft kidneys in Hong Kong. Chan KW, Chan GS, Tang S. Transplant Proc; 2005 Dec 27; 37(10):4293-6. PubMed ID: 16387100 [Abstract] [Full Text] [Related]
34. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Jeong HJ, Kim YS, Kwon KH, Kim SI, Kim MS, Choi KH, Lee HY, Han DS, Park K. Pathol Int; 2004 Nov 27; 54(11):837-42. PubMed ID: 15533226 [Abstract] [Full Text] [Related]
35. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Artz MA, Hilbrands LB, Borm G, Assmann KJ, Wetzels JF. Nephrol Dial Transplant; 2004 Nov 27; 19(11):2852-7. PubMed ID: 15466882 [Abstract] [Full Text] [Related]
36. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Oka K, Imai E, Moriyama T, Akagi Y, Ando A, Hori M, Okuyama A, Toki K, Kyo M, Kokado Y, Takahara S. Nephrol Dial Transplant; 2000 May 27; 15(5):689-95. PubMed ID: 10809812 [Abstract] [Full Text] [Related]
37. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)]. Takao T, Hatori M, Ichimaru N, Honda M, Nonomura N, Matsumiya K, Kokado Y, Takahara S, Okuyama A, Miyamoto M, Yokoyama K, Imai E, Kyo M. Hinyokika Kiyo; 1997 Sep 27; 43(9):661-4. PubMed ID: 9365847 [Abstract] [Full Text] [Related]
38. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation. Coppo R, Amore A, Chiesa M, Lombardo F, Cirina P, Andrulli S, Passerini P, Conti G, Peruzzi L, Giraudi R, Messina M, Segoloni G, Ponticelli C. Clin Transplant; 2007 Sep 27; 21(6):728-37. PubMed ID: 17988266 [Abstract] [Full Text] [Related]
39. A single-center study of the technical aspects and outcome of third and subsequent renal transplants. Hagan C, Hickey DP, Little DM. Transplantation; 2003 May 27; 75(10):1687-91. PubMed ID: 12777857 [Abstract] [Full Text] [Related]
40. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Moore J, He X, Cockwell P, Little MA, Johnston A, Borrows R. Transplantation; 2008 Aug 27; 86(4):564-70. PubMed ID: 18724227 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]